Loading: 100%
MGC DIAGNOSTICS Corp logo
no logo available
General Information
Investor relations pageIR page no data available
Founding year no data available
Headquarter , , no data available
Employees 155 (as per Q3 2016)no data available
Sector Medical Devices, HealthcareMedical Devices, Healthcareno data available
Ticker MGCDno data available
Financial year endsFY ends End of Octoberno data available
Stock Information (historical prices adjusted for splits and dividends)
Adj. Closing prices (in USD) -Common sharesNov. 16Jan. 17März 17Mai 17Juli 17Sep. 17678910
datesClosing price (adj.)
13.10.20178.88
11.10.20179.10
04.10.20179.05
27.09.20178.16
20.09.20178.10
13.09.20178.13
06.09.20178.19
30.08.20178.08
23.08.20177.91
16.08.20178.17
09.08.20177.99
02.08.20178.01
26.07.20178.03
19.07.20178.51
12.07.20178.20
05.07.20178.40
27.06.20178.07
20.06.20178.12
13.06.20178.32
06.06.20177.49
30.05.20178.13
23.05.20178.31
16.05.20178.26
09.05.20178.38
02.05.20178.50
25.04.20178.52
18.04.20178.30
11.04.20178.05
04.04.20178.15
28.03.20178.30
21.03.20178.98
14.03.20178.57
07.03.20179.83
28.02.20179.91
21.02.20179.00
14.02.20179.20
07.02.20179.41
31.01.20178.17
24.01.20177.13
17.01.20177.22
10.01.20177.35
03.01.20177.36
27.12.20167.25
19.12.20167.04
12.12.20166.84
05.12.20167.02
28.11.20167.22
21.11.20166.99
14.11.20166.94
07.11.20166.90
31.10.20167.02
24.10.20166.76
17.10.20166.76
no share price data source found
Share price data requested
Key Figures
Last Closing Price
as per Oct 13, 2017, in USD
8.88n/a
Market Capitalisation
in million USD
39n/a
Enterprise Value
in million USD
33n/a
Common Shares Outstanding
as per Jul 31, 2016
4,336,581n/a
Preferred Shares Outstanding
as per Jul 31, 2016
n/a
Average Basic Shares Outstanding
TTM
4,296,250n/a
Average Diluted Shares Outstanding
TTM
4,304,500n/a
Index Membership
n/a
Business Summary
MGC Diagnostics Corp designs, markets, and sells non-invasive cardiorespiratory diagnostic products in hospitals, university-based medical centers, medical clinics, pharmaceutical companies, medical device manufacturers and clinical research organization.
no data available
Key Financials & Ratios (all figures TTM as per Jul 31, 2016, million USD, full statements further below)
Profit & Loss
Revenues 39n/a
Gross Profit 21n/a
Operating Income 2n/a
EBITDA 3n/a
Net Profit 1n/a
Balance Sheet
Cash and Cash Equivalents 6n/a
Receivables 6n/a
Total Current Assets 20n/a
PP&E 3n/a
Total Assets 33n/a
Accounts Payable 2n/a
Current Debt 0n/a
Total Current Liabilities 9n/a
Long-Term Debt 0n/a
Total Liabilities 13n/a
Total Equity 21n/a
Cash Flow
Depreciation & Amortisation 1n/a
Change in Working Capital 1n/a
Operating Cash Flow 4n/a
Net Change in PP&E and Intangibles -1n/a
Investing Cash Flow -1n/a
Dividends Paid 0n/a
Financing Cash Flow -3n/a
Total Change in Cash 0n/a
Free Cash Flow 3n/a
Profitability Ratios
Gross Margin 52.6%n/a
Operating Margin 4.4%n/a
Net Profit Margin 3.4%n/a
Return on Equity 6.3%n/a
Return on Assets 3.9%n/a
Per Share Figures
Basic EPS 0.31n/a
Diluted EPS 0.31n/a
Sales per Share 9.10n/a
Book Value per Share 4.85n/a
FCF per Share 0.67n/a
Dividends per Share 0.00n/a
Price Multiples
Price to Earnings Ratio 29.06n/a
Price to Sales Ratio 0.98n/a
Price to Book Value 1.83n/a
Price to Free Cash Flow 13.28n/a
Valuation Metrics
EV/EBITDA 11.87n/a
EV/Sales 0.84n/a
Book to Market Value 0.54n/a
Other Ratios
Current Ratio 231.1%n/a
Liabilities to Equity Ratio 60.4%n/a
Debt to Assets Ratio 0.0%n/a
Profit & Loss StatementP&L data quality: 100% (?)
edit
No data available yet
Loading data...
No data available for the original financial statements for the selected time periods. You can change the selected time periods by clicking on 'data' on the top right.
Standardised statements can't be displayed.
Reason:
No data available for the selected time periods
in million USD FY '10FY '11FY '12FY '13FY '14FY '15
Revenue
29
27
27
32
30
37
Sales & Services Revenue
29
27
27
32
30
37
Financing Revenue
0
0
0
0
0
0
Other Revenue
0
0
0
0
0
0
Cost of revenue
-13
-12
-12
-14
-14
-18
Cost of Goods & Services
-13
-12
-12
-14
-14
-18
Cost of Financing Revenue
0
0
0
0
0
0
Cost of Other Revenue
0
0
0
0
0
0
Gross Profit
16
15
15
18
16
19
Other Operating Income
0
0
0
0
0
0
Operating Expenses
-17
-15
-16
-16
-17
-18
Selling, General & Administrative
-13
-11
-12
-14
-14
-15
Selling & Marketing
0
0
0
0
0
0
General & Administrative
0
0
0
0
0
0
Research & Development
-4
-3
-3
-2
-3
-3
Depreciation & Amortization
0
0
0
0
0
0
Provision For Doubtful Accounts
0
0
0
0
0
0
Other Operating Expense
0
0
0
0
0
0
Operating Income (Loss)
-1
1
-1
1
-1
2
Non-Operating Income (Loss)
0
0
0
0
0
0
Interest Expense, net
0
0
0
0
0
0
Interest Expense
0
0
0
0
0
0
Interest Income
0
0
0
0
0
0
Other Investment Income (Loss)
0
0
0
0
0
0
Foreign Exchange Gain (Loss)
0
0
0
0
0
0
Income (Loss) from Affiliates
0
0
0
0
0
0
Other Non-Operating Income (Loss)
0
0
0
0
0
0
Pretax Income (Loss), Adjusted
-1
1
-1
1
-1
1
Abnormal Gains (Losses)
0
0
0
0
0
-1
Acquired In-Process R&D
0
0
0
0
0
0
Merger / Acquisition Expense
0
0
0
0
0
0
Abnormal Derivatives
0
0
0
0
0
0
Disposal of Assets
0
0
0
0
0
0
Early extinguishment of Debt
0
0
0
0
0
0
Asset Write-Down
0
0
0
0
0
0
Impairment of Goodwill & Intangibles
0
0
0
0
0
0
Sale of Business
0
0
0
0
0
0
Legal Settlement
0
0
0
0
0
0
Restructuring Charges
0
0
0
0
0
0
Sale of and Unrealized Investments
0
0
0
0
0
0
Insurance Settlement
0
0
0
0
0
0
Other Abnormal Items
0
0
0
0
0
0
Pretax Income (Loss)
-1
1
-1
1
-1
0
Income Tax (Expense) Benefit, net
0
0
0
0
0
4
Current Income Tax
0
0
0
0
0
0
Deferred Income Tax
0
0
0
0
0
0
Tax Allowance/Credit
0
0
0
0
0
0
Income (Loss) from Affiliates, net of taxes
0
0
0
0
0
0
Income (Loss) from Continuing Operations
-1
1
-1
1
-1
4
Net Extraordinary Gains (Losses)
0
-1
1
0
0
0
Discontinued Operations
0
-1
1
0
0
0
XO & Accounting Charges & Other
0
0
0
0
0
0
Income (Loss) Including Minority Interest
-1
0
0
1
-1
4
Minority Interest
0
0
0
0
0
0
Net Income
-1
0
0
1
-1
4
Preferred Dividends
0
0
0
0
0
0
Other Adjustments
0
0
0
0
0
0
Net Income Available to Common Shareholders
-1
0
0
1
-1
4
Remarks
restated on Jan 27, 2012 n/a
calculated values,
restated on Jan 29, 2013 n/a
calculated values,
restated on Jan 28, 2014 n/a
calculated values,
restated on Jan 29, 2015 n/a
calculated values,
restated on Jan 29, 2016 n/a
calculated values,
restated on Jan 29, 2016 n/a
calculated values,
Balance SheetBS data quality: 100% (?)
edit
No data available yet
Loading data...
No data available for the original financial statements for the selected time periods. You can change the selected time periods by clicking on 'data' on the top right.
Standardised statements can't be displayed.
Reason:
No data available for the selected time periods
in million USD FY '10FY '11FY '12FY '13FY '14FY '15
Assets
Cash, Cash Equivalents & Short Term Investments
10
9
10
11
6
7
Cash & Cash Equivalents
7
8
10
11
6
7
Short Term Investments
3
1
0
0
0
0
Accounts & Notes Receivable
5
6
6
8
7
7
Accounts Receivable, Net
5
6
6
8
7
7
Notes Receivable, Net
0
0
0
0
0
0
Unbilled Revenues
0
0
0
0
0
0
Inventories
4
4
4
3
6
7
Raw Materials
0
0
0
0
0
0
Work In Process
0
0
0
0
0
0
Finished Goods
0
0
0
0
0
0
Other Inventory
0
0
0
0
0
0
Other Short Term Assets
0
0
1
1
2
1
Prepaid Expenses
0
0
1
1
2
1
Derivative & Hedging Assets
0
0
0
0
0
0
Assets Held-for-Sale
0
0
0
0
0
0
Deferred Tax Assets
0
0
0
0
0
0
Income Taxes Receivable
0
0
0
0
0
0
Discontinued Operations
0
0
0
0
0
0
Miscellaneous Short Term Assets
0
0
0
0
0
0
Total Current Assets
19
19
20
23
21
22
Property, Plant & Equipment, Net
1
0
1
1
3
3
Property, Plant & Equipment
0
0
0
0
0
0
Accumulated Depreciation
0
0
0
0
0
0
Long Term Investments & Receivables
1
0
0
0
0
0
Long Term Investments
0
0
0
0
0
0
Long Term Marketable Securities
0
0
0
0
0
0
Long Term Receivables
0
0
0
0
0
0
Other Long Term Assets
1
1
2
2
8
11
Intangible Assets
1
1
1
2
4
4
Goodwill
0
0
0
0
4
3
Other Intangible Assets
0
0
0
0
0
0
Prepaid Expense
0
0
0
0
0
0
Deferred Tax Assets
0
0
0
0
0
3
Derivative & Hedging Assets
0
0
0
0
0
0
Prepaid Pension Costs
0
0
0
0
0
0
Discontinued Operations
0
0
0
0
0
0
Investments in Affiliates
0
0
0
0
0
0
Miscellaneous Long Term Assets
0
0
0
0
0
0
Total Noncurrent Assets
3
2
2
3
12
14
Total Assets
21
21
22
26
32
36
Liabilities and owners' equity
Payables & Accruals
2 2359000
2 2243000
3 2627000
3 2776000
5 4577000
4 4110000
Accounts Payable
2 1951000
2 2022000
2 2094000
2 1871000
3 3161000
3 2617000
Accrued Taxes
0 0
0 0
0 0
0 0
0 0
0 0
Interest & Dividends Payable
0 0
0 0
0 0
0 0
0 0
0 0
Other Payables & Accruals
0 408000
0 221000
1 533000
1 905000
1 1416000
1 1493000
Short Term Debt
0 0
0 0
0 0
0 0
1 786000
1 785000
Short Term Borrowings
0 0
0 0
0 0
0 0
0 0
0 0
Short Term Capital Leases
0 0
0 0
0 0
0 0
0 0
0 0
Current Portion of Long Term Debt
0 0
0 0
0 0
0 0
0 0
0 0
Other Short Term Liabilities
4 3812000
3 3393000
4 3676000
5 5036000
5 5468000
5 5462000
Deferred Revenue
2 1522000
2 1771000
2 1927000
3 3091000
4 3804000
4 3608000
Derivatives & Hedging
0 0
0 0
0 0
0 0
0 0
0 0
Deferred Tax Liabilities
0 0
0 0
0 0
0 0
0 0
0 0
Discontinued Operations
0 0
0 0
0 0
0 0
0 0
0 0
Miscellaneous Short Term Liabilities
2 2290000
2 1622000
2 1749000
2 1945000
2 1664000
2 1854000
Total Current Liabilities
6 6171000
6 5636000
6 6303000
8 7812000
11 10831000
10 10357000
Long Term Debt
0 0
0 0
0 0
0 0
3 2947000
2 2158000
Long Term Borrowings
0 0
0 0
0 0
0 0
0 0
0 0
Long Term Capital Leases
0 0
0 0
0 0
0 0
0 0
0 0
Other Long Term Liabilities
1 873000
1 817000
1 895000
3 2535000
3 3161000
3 3146000
Accrued Liabilities
0 0
0 0
0 0
0 0
0 0
0 0
Pension Liabilities
0 0
0 0
0 0
0 0
0 0
0 0
Pensions
0 0
0 0
0 0
0 0
0 0
0 0
Other Post-Retirement Benefits
0 0
0 0
0 0
0 0
0 0
0 0
Deferred Compensation
0 0
0 0
0 0
0 0
0 0
0 0
Deferred Revenue
1 873000
1 817000
1 895000
3 2535000
3 2814000
3 3146000
Deferred Tax Liabilities
0 0
0 0
0 0
0 0
0 347000
0 0
Derivatives & Hedging
0 0
0 0
0 0
0 0
0 0
0 0
Discontinued Operations
0 0
0 0
0 0
0 0
0 0
0 0
Miscellaneous Long Term Liabilities
0 0
0 0
0 0
0 0
0 0
0 0
Total Noncurrent Liabilities
1 873000
1 817000
1 895000
3 2535000
6 6108000
5 5304000
Total Liabilities
7 7044000
6 6453000
7 7198000
10 10347000
17 16939000
16 15661000
Preferred Equity
0 0
0 0
0 0
0 0
0 0
0 0
Share Capital & Additional Paid-In Capital
21 20861000
21 21000000
21 21434000
23 23019000
24 23890000
25 24545000
Common Stock
0 0
0 0
0 0
0 0
0 0
0 0
Additional Paid in Capital
0 0
0 0
0 0
0 0
0 0
0 0
Other Share Capital
0 0
0 0
0 0
0 0
0 0
0 0
Treasury Stock
0 0
0 0
0 0
0 0
0 0
0 0
Retained Earnings
-7 -6531000
-7 -6683000
-7 -6684000
-7 -7175000
-8 -8331000
-4 -4355000
Other Equity
0 7000
0 2000
0 0
0 0
0 -114000
0 -263000
Equity Before Minority Interest
14 14337000
14 14319000
15 14750000
16 15844000
15 15445000
20 19927000
Minority Interest
0 0
0 0
0 0
0 0
0 0
0 0
Total Equity
14 14337000
14 14319000
15 14750000
16 15844000
15 15445000
20 19927000
Total Liabilities & Equity
21 21381000
21 20772000
22 21948000
26 26191000
32 32384000
36 35588000
Remarks restated on Jan 27, 2012 n/a restated on Jan 29, 2013 n/a restated on Jan 28, 2014 n/a restated on Jan 29, 2015 n/a restated on Jan 29, 2016 n/a restated on Sep 14, 2016 n/a
Cash Flow StatementCF data quality: 96% (?)
edit
No data available yet
Loading data...
No data available for the original financial statements for the selected time periods. You can change the selected time periods by clicking on 'data' on the top right.
Standardised statements can't be displayed.
Reason:
No data available for the selected time periods
in million USD FY '10FY '11FY '12FY '13FY '14FY '15
Net Income/Starting Line
-1
0
0
1
-1
4
Net Income
0
0
0
0
0
0
Net Income From Discontinued Operations
0
0
0
0
0
0
Other Adjustments
0
0
0
0
0
0
Depreciation & Amortization
1
1
1
0
1
1
Non-Cash Items
1
0
0
0
1
-2
Stock-Based Compensation
0
0
0
0
0
0
Deferred Income Taxes
0
0
0
0
0
0
Other Non-Cash Adjustments
0
0
0
0
0
0
Change in Working Capital
1
-1
1
0
0
-1
(Increase) Decrease in Accounts Receivable
0
0
0
0
0
0
(Increase) Decrease in Inventories
0
0
0
0
0
0
Increase (Decrease) in Accounts Payable
0
0
0
0
0
0
Increase (Decrease) in Other
0
0
0
0
0
0
Net Cash From Discontinued Operations (operating)
0
0
0
0
0
0
Cash from Operating Activities
2
0
1
2
0
2
Change in Fixed Assets & Intangibles
0
-1
-1
-1
-1
-1
Disposition of Fixed Assets & Intangibles
0
0
0
0
0
0
Disposition of Fixed Assets
0
0
0
0
0
0
Disposition of Intangible Assets
0
0
0
0
0
0
Acquisition of Fixed Assets & Intangibles
0
0
0
0
0
0
Purchase of Fixed Assets
0
0
0
0
0
0
Acquisition of Intangible Assets
0
0
0
0
0
0
Other Change in Fixed Assets & Intangibles
0
0
0
0
0
0
Net Change in Long Term Investment
-3
3
1
0
0
0
Decrease in Long Term Investment
0
0
0
0
0
0
Increase in Long Term Investment
0
0
0
0
0
0
Net Cash From Acquisitions & Divestitures
0
0
0
0
-8
0
Net Cash from Divestitures
0
0
0
0
0
0
Cash for Acqusition of Subsidiaries
0
0
0
0
0
0
Cash for Joint Ventures
0
0
0
0
0
0
Net Cash from Other Acquisitions
0
0
0
0
0
0
Other Investing Activities
0
0
1
0
0
0
Net Cash From Discontinued Operations (investing)
0
0
0
0
0
0
Cash from Investing Activities
-4
2
0
-1
-9
0
Dividends Paid
0
0
0
-2
0
0
Cash From (Repayment of) Debt
0
0
0
0
4
-1
Cash From (Repayment of) Short Term Debt, net
0
0
0
0
0
0
Cash From (Repayment of) Long Term Debt, net
0
0
0
0
0
0
Repayments of Long Term Debt
0
0
0
0
0
0
Cash From Long Term Debt
0
0
0
0
0
0
Cash From (Repurchase of) Equity
-2
0
0
1
0
0
Increase in Capital Stock
0
0
0
1
0
0
Decrease in Capital Stock
-2
0
0
0
0
0
Other Financing Activities
0
0
0
0
0
0
Net Cash From Discontinued Operations (financing)
0
0
0
0
0
0
Cash from Financing Activities
-2
0
0
-1
4
-1
Net Cash Before Disc. Operations and FX
-4
2
1
1
-5
1
Change in Cash from Disc. Operations and Other
0
0
0
0
0
0
Net Cash Before FX
-4
2
1
1
-5
1
Effect of Foreign Exchange Rates
0
0
0
0
0
0
Net Changes in Cash
-4
2
1
1
-5
1
Remarks
restated on Jan 27, 2012 n/a
calculated values,
restated on Jan 29, 2013 n/a
calculated values,
restated on Jan 28, 2014 n/a
calculated values,
restated on Jan 29, 2015 n/a
calculated values,
restated on Jan 29, 2016 n/a
calculated values,
restated on Jan 29, 2016 n/a
calculated values,
Some of the data shown on this page is provided for free by IEX
Sumo